Receive our newsletter – data, insights and analysis delivered to you
  1. News
November 20, 2019

Novartis invests in SiO2 to use material sciences for packaging tech

Swiss pharmaceutical company Novartis has made a strategic investment in US-based biotech industries packaging company SiO2 Medical Products.

Swiss pharmaceutical company Novartis has made a strategic investment in US-based biotech industries packaging company SiO2 Medical Products.

Healthcare investment firm MPM Capital co-led the investment.

Novartis will gain access to use SiO2’s patented materials sciences for packaging technology.

In a joint statement, SiO2 Scientific board leaders Dr Robert Pangborn and Dr Bob Langer said: “Novartis shares our vision for advancing technology to bring better patient outcomes. We believe this collaboration is one of the first of its kind where using advanced materials science in drug delivery may help improve patients’ lives.”

SiO2 produces precision-moulded Cyclic Olefin Polymer (COP) primary drug containers, featuring a coating system. The thin, transparent, silicon-based coating system is made up of organosiloxane and silica Nano-layers.

SiO2 will initially use the technology for ophthalmic applications and based on the results would implement it for various products.

Content from our partners
Cutting-edge innovation in fish packaging
Newtec’s new hyperspectral imaging camera

It offers enhanced packaging and it also meets quality and safety standards for biologics and operational savings.

SiO2 board director and MPM Capital executive partner Tony Rosenberg said: “SiO2’s leadership combined with the Novartis collaboration, positions the organisation for future success.

“SiO2’s innovative surface coating technology of primary drug containers has the potential to enable innovation across a wide range of products during the development cycle up to the final market presentation.”

In September, SiO2 signed an agreement to manufacture and commercialise multi-well plates treated with BioDep tissue coating technologies developed by TheraDep.

Currently, the company is building a new facility near Basel, Switzerland.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The packaging industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU